Galena Biopharma (GALE)
Create an Alert
2.07
-0.01 -0.48%
NASDAQ
Jun 19, 5:00PM
BATS Real time
Currency in USD
Galena Biopharma SG&A Expense Quarterly:
1.517M for Dec. 31, 2012Galena Biopharma Historical SG&A Expense Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 1.517M |
| Sept. 30, 2012 | 1.359M |
| June 30, 2012 | 1.963M |
| March 31, 2012 | 1.939M |
| Dec. 31, 2011 | 1.499M |
| Sept. 30, 2011 | 2.068M |
| June 30, 2011 | 1.949M |
| March 31, 2011 | 3.119M |
| Dec. 31, 2010 | 1.949M |
| Sept. 30, 2010 | 1.783M |
| June 30, 2010 | 2.49M |
| March 31, 2010 | 2.53M |
| Dec. 31, 2009 | 1.933M |
About SG&A Expense
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
The details of how SG&A expenses are calculated vary widely from company to company, so YCharts recommends looking at the annual report (10-k) an investor is interested in dissecting this number further.
Learn More
GALE SG&A Expense Quarterly Benchmarks
| Companies | |
|---|---|
| Celldex Therapeutics | 3.138M |
| ImmunoCellular Therapeutics | 0.9334M |
| Northwest Biotherapeutics | 2.47M |
GALE SG&A Expense Quarterly Rankings
| Overall |
62nd percentile 6318 of 16782 |
| Sector |
53rd percentile 650 of 1410 in Healthcare |
| Industry |
53rd percentile 210 of 454 in Biotechnology |
GALE SG&A Expense Quarterly Range, Past 5 Years
| Minimum | 1.359M | Sep 2012 |
| Maximum | 3.119M | Mar 2011 |
| Average | 2.029M |
